An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinoma

Q. Davies, A.C. Perkins, J.C. Roos, C.F.M. Molthoff, RHM Verheijen, M. Frier, P. Kenemans, T.J. Broadhead, M. Sopwith, E.M. Symonds

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)31-37
JournalBritish Journal of Obstetrics and Gynaecology
Volume106
Publication statusPublished - 1999

Cite this